コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 1p15.5 H19/ICR1 epigenetic hypermethylation (loss of imprinting).
2 id incompatibility has indeed been linked to loss of imprinting.
3 methyltransferase DNMT1 causes a widespread loss of imprinting.
4 In vitro culture of mouse embryos results in loss of imprinting.
5 is biallelic in G9a -/- ES cells, indicating loss of imprinting.
6 Removal of a gene's DMD leads to a loss of imprinting.
7 ence of methylation of SNRPN consistent with loss of imprinting.
8 of 27 tumors informative for IGF2 manifested loss of imprinting.
9 tion in both wild-type and mutant mice, with loss of imprinting.
10 3 promoter in primary human gliomas led to a loss of imprinting and decreased PEG3 mRNA expression th
11 Choriocarcinomas are embryonal tumours with loss of imprinting and hypermethylation at the insulin-l
13 normally silent maternal Dlk1 in offspring (loss of imprinting) and increased DNA methylation at the
14 elapse with loss of heterozygosity, 25% with loss of imprinting, and 3.3% relapse with retention of t
15 vents, such as promoter hypermethylation and loss of imprinting, are also involved in carcinogenesis.
17 tations in WT1 and loss of heterozygosity or loss of imprinting at 11p15, which results in biallelic
23 hese data indicating environmentally induced loss of imprinting at VTRNA2-1 constitute a plausible ca
24 and the vulnerability of imprinted genes to loss of imprinting changes, there has been extensive spe
25 hat misregulation of non-imprinted genes and loss-of-imprinting characterize the ART-induced overgrow
26 this dynamic period and to determine whether loss of imprinting continues at later stages of developm
29 The maternally expressed gene DLX5 showed a loss of imprinting in lymphoblastoid cells from individu
30 The discrepancy between IGF2 and IGF2-AS loss of imprinting in some tumors demonstrates the contr
31 ted head and neck squamous carcinoma for the loss of imprinting in the IGF2 and H19 genes to determin
32 ncreased maternal allele expression of Igf2 (loss of imprinting) in adenoma which form, despite pater
34 by in vitro reprogramming, and suggest that loss of imprinting is associated with the loss of activi
35 f 5-aza-2'-deoxycytidine on tumor cells with loss of imprinting is not random but specific to one all
36 arental inheritance of chromosome 11p15, and loss of imprinting is observed in several cancers includ
46 s, and some developmental disorders, exhibit loss of imprinting (LOI) in key genes such as insulin-li
54 tion patterns at imprinted loci resulting in loss of imprinting (LOI) may lead to serious imprinting
56 ic acid supplementation during pregnancy and loss of imprinting (LOI) of IGF2 and H19 genes in placen
58 expression, and suggest a new mechanism for loss of imprinting (LOI) of Igf2, which may be important
62 a recent study showing that a mouse model of loss of imprinting (LOI) of the insulin-like growth fact
63 thylation and promoter hypermethylation, and loss of imprinting (LOI) of the insulin-like growth fact
70 ics recapitulate those observed in the human loss-of-imprinting (LOI) overgrowth syndrome Beckwith-Wi
71 locus in LOI cancer cells suggests that the loss of imprinting may lead to a variety of changes in g
73 egulated in testicular germ cell tumors, and loss of imprinting occurs frequently in testicular semin
76 t synthesize gamma-aminobutyric acid (GABA), loss of imprinting of Dlx5 may alter GABAergic neuron ac
77 ncluding infrequent mutation of p57(KIP2) or loss of imprinting of either of two imprinted gene domai
79 Paternal inheritance of Ex1A-T-CON leads to loss of imprinting of Gsalpha, resulting in preweaning g
80 t a similar mechanism may be responsible for loss of imprinting of IGF-II in normal brain and Wilms'
81 that show loss of heterozygosity of 11p15 or loss of imprinting of IGF2 also silence HOTS (7/7 and 10
83 informative for the ApaI IGF2 polymorphism, loss of imprinting of IGF2 was observed in both normal a
85 e LOI of IGF2, only two of six tumors showed loss of imprinting of IGF2-AS, whereas four of six tumor
93 overed a novel genetic alteration in cancer, loss of imprinting, which affects several of these genes